![]() |
|
|
Induced COX-2 Pathways in Colon Cancer Cells1


Institute of General Pathology,
* Institute of Pathology,
Institute of Pharmacology, and
** Institute of Histology, Catholic University, 00168 Rome, Italy
2To whom correspondence should be addressed. E-mail: p.palozza{at}rm.unicatt.it.
Experimental studies have shown that ß-carotene inhibited the growth of colon cancer cells, and human trials have demonstrated that the carotenoid reduces colon cell proliferation of adenomatous polyps; however, molecular mechanisms underlying this chemopreventive activity remain unclear. Because COX-2 has been implicated as a causative factor in colon carcinogenesis, the present study was designed to investigate the relation between the growth-inhibitory effect of the carotenoid and COX-2 expression in colon cancer cells. We evaluated the effects of ß-carotene on the growth of human colon adenocarcinoma cells overexpressing (LS-174, HT-29, WiDr) or not expressing (HCT116) COX-2. We also studied COX-2 expression induced by heregulin-
, apoptosis induction, reactive oxygen species (ROS) production, and extracellular signalregulated kinase 1/2 (ERK1/2) activation. ß-Carotene (0.52.0 µmol/L) decreased COX-2 expression (P < 0.05) and prostaglandin E2 (PGE2) production (P < 0.05) in colon cancer cells. This effect was not observed in cells treated with retinoic acid or retinol. The downregulation of COX-2 by the carotenoid occurred in both untreated and heregulin-treated cells. It was accompanied by an increased ability of cells to undergo apoptosis and by a decrease in intracellular ROS production and in the activation of ERK1/2. Moreover, cells not expressing COX-2 were insensitive to the growth-inhibitory and proapoptotic effects of the carotenoid. Here, we report that the suppression of COX-2 by ß-carotene may represent a molecular mechanism by which this compound acts as an antitumor agent in colon carcinogenesis.
KEY WORDS: ß-carotene COX-2 expression cell growth apoptosis colon cancer cells
This article has been cited by other articles:
![]() |
Y. NAKAYAMA, Y. INOUE, N. MINAGAWA, K. ONITSUKA, J. NAGATA, K. SHIBAO, K. HIRATA, T. SAKO, N. NAGATA, and K. YAMAGUCHI Chemopreventive Effect of 4-[3,5-Bis(trimethylsilyl) benzamido] Benzoic Acid (TAC-101) on MNU-induced Colon Carcinogenesis in a Rat Model Anticancer Res, June 1, 2009; 29(6): 2059 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Chow The Relative Efficacy of Lycopene and {beta}-Carotene in Inhibiting Experimental Metastasis of Human Hepatoma SK-Hep-1 Cells in Athymic Nude Mice J. Nutr., November 1, 2008; 138(11): 2289 - 2289. [Full Text] [PDF] |
||||
![]() |
P. Senesse, M. Touvier, E. Kesse, J. Faivre, and M.-C. Boutron-Ruault Tobacco Use and Associations of {beta}-Carotene and Vitamin Intakes with Colorectal Adenoma Risk J. Nutr., October 1, 2005; 135(10): 2468 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Touvier, E. Kesse, F. Clavel-Chapelon, and M.-C. Boutron-Ruault Dual Association of {beta}-Carotene With Risk of Tobacco-Related Cancers in a Cohort of French Women J Natl Cancer Inst, September 21, 2005; 97(18): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||